Antitumor agent-125
Antitumor agent-125 (compound 17A) is a novel platinum (IV) prodrug. Antitumor agent-125 can activate the mitochondrion-dependent apoptosis pathway. Antitumor agent-125 induces ferroptosis in HCT-116/OXA[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Apoptosis; Ferroptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-125.html
Solubility
10 mM in DMSO
Smiles
Cl[Pt]12([NH2][C@@H]3CCCC[C@H]3[NH2]1)(OC(COC4=C(C=CC(C(/C=C/C(C(C)=N5)=NC(C)=C5C)=O)=C4)OC)=O)OC(C(O2)=O)=O
Molecular Formula
C27H33ClN4O9Pt
Molecular Weight
788.11
References & Citations
[1]Zhikun Liu, et al. Novel Platinum (IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis. Eur J Med Chem. 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP304263M 100 µg
C7orf30 (MALSU1) (NM_138446) Human Recombinant Protein
Sign In for Pricing
View Details 
GP-8003-5 1 mL
Colloidal Gold Conjugated Aegopodium podagraria Lectin (Ground Elder) -APP-, 5nm
Sign In for Pricing
View Details 